Our Bureau

New Delhi, Oct. 3

, THE BSE has withdrawn the notice of suspension of dealing in securities of Polar Pharma on the exchange, said a company statement.

The notice was issued to the company as it had not complied with certain provisions in the listing agreements. "But in fact, all the compliances were complied with and there were no delays/defaults. The same was apprised to the stock exchange, based on which the suspension has been withdrawn," it said.

(This article was published in the Business Line print edition dated October 4, 2005)
XThese are links to The Hindu Business Line suggested by Outbrain, which may or may not be relevant to the other content on this page. You can read Outbrain's privacy and cookie policy here.